Replies to post #61877 on Ariad Pharmaceuticals Inc fka ARIA

[vidpok45]

You are right about AF....Just a puppet and not a very bright one at that. LDK378 is completely inferior to 113, and that was obvious even a couple of years ago. What is somewhat surprising is Ponatinib's widespread acceptance despite its toxicity. What has me very excited is its apparent synergy with chemo therapy which could lead to a huge market which will dwarf its current indications. Having Ponatinib, 113, and the mystery molecule and new leadership hopefully soon should get the stock back to where it was pre crash and certainly higher over time if it isnt acquired.....a win/win for everyone here except the shorts.

[Whosetosay]

AF was lucky, so he may very well be the dirtbag he is accused by so many including me. My recollection, he did no research beyond stumbling upon a hit piece by a Dr. Favus, and then broadcasting it. Turns out to have 100% on the money, so I do pay some attention to other negative comments from time to time, especially on Pona. Shorty made money as the stock nosedived until HB said what he said. Little did we know all that would come back to haunt investors and HB.

I presume AF has ran out of luck as '113 seems to be the real deal. Again, '113 is likely the franchise drug, and decisions must be made not at its expense, but for its expenses, until it maxes its labels.